Screener
Biogen BIIB Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Biogen in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: Biogen’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 6:36 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000875045-26-000075
| Line item | As of June 30, 2026 | As of December 31, 2025 |
|---|---|---|
| Total current liabilities | 3,917.1 | 3,349.4 |
| Notes payable and term loan | 7,290.3 | 6,286.8 |
| Deferred tax liability | 945.5 | 507.6 |
| Long-term operating lease liabilities | 264.8 | 290.4 |
| Other long-term liabilities | 820.9 | 748.5 |
| Total liabilities | 13,238.6 | 11,182.7 |
| Commitments, contingencies and guarantees | ||
| Equity: |
Item 1. Financial Statements (unaudited)
FAQ
- What is Biogen's operating lease liabilities?
- Biogen (BIIB) reported operating lease liabilities of $264.8M in Q2 2026.
- How has Biogen's operating lease liabilities changed year-over-year?
- Biogen's operating lease liabilities decreased by 14.8% year-over-year, from $310.9M to $264.8M.
- What is the long-term trend for Biogen's operating lease liabilities?
- Over 5 years (2020 to 2025), Biogen's operating lease liabilities has grown at a -6.3% compound annual growth rate (CAGR), from $402M to $290.4M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about Biogen's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude